Subscribe
type here...
Subscribe

Tag: Investments

Medisorb to Invest 100 Million Rubles Under First Regional Offset Contract

News Pharma -
The Ministry of Health of the Perm Region and Medisorb JSC have signed the region's first-ever offset contract. The...

“RBT” to Direct 60 Million Rubles to Vaccine Development and New Products

News Pharma -
Shareholders of the biotech company JSC "RBT" (part of the "Artgen Biotech" ecosystem) have approved a decision to increase...

Pharma Giant Nobel Invests 40 Billion Tenge in New Plant Construction in Kazakhstan

EAEU Market Pharma -
The Ministry of Health of the Republic of Kazakhstan has signed a major investment agreement with the Turkish company...

Big Pharma Companies Expand in China: Investment Overview for 2026

Global Markets Pharma -
By 2026, China is completing its transformation from a global generics manufacturing site into a world-class biotechnology hub. Despite...

Amgen sells its Turkish manufacturing arm for $135M

Global Markets Pharma -
Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta...

Pfizer and BioNTech announce new $3.2 billion agreement to supply the COVID-19 vaccine to the US

Global Markets Pharma -
Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which...

Fujifilm plans a $1.6 billion expansion at CDMO facilities in Denmark and Texas

Global Markets Pharma -
Fujifilm isn’t slowing down on its expansion roll. Just a few months after it bought Shanandoah Biotechnology for an...

Spero Therapeutics plummets 15% as FDA rejects new drug application

Global Markets Pharma -
Spero Therapeutics , Inc. shares plunged around 15% after-hours following the company’s announcement, according to which the U.S. Food...

Sutro Biopharma shares soar 67% due to cooperation with Astellas in cancer treatment

Global Markets Pharma -
Sutro Biopharma Inc. shares leaped 67% to $7.24 a share in U.S. after-hours trading after the South San Francisco...

Biotech investors focus on biotechs with drugs closer to market

Global Markets Pharma -
Biotech investors nursing losses from stock price falls are now focusing on firms which are closer to getting their...

Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug

Global Markets Pharma -
A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying...

Gurnet Point Capital, Patient Square Capital agreed to pay up to $890 million for biotechnology

Global Markets Pharma -
Radius Health, a maker of bone and cancer drugs, has agreed to be taken private in an acquisition worth...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

South Korea Develops Chitosan-Based Powder That Stops Bleeding in 1 Second

0
A team of scientists from the Korea Advanced Institute...

Biopharma 2026: End of “Winter” and the Dawn of a New Era. A Comprehensive Analytical Review

0
After four years of "hunkering down," the global biopharmaceutical...

A Pharma Plant Within University Walls: PSU Launches Drug Production Based on Spruce Cones

0
Perm State University (PSU) is moving from theory to...

TPU Scientists Develop Technology for Instant Quality Control of Pharmaceutical Packaging

0
TOMSK — Scientists from Tomsk Polytechnic University (TPU) have...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Privacy Policy

© PHARMPROM 2026